Vector Group completes Douglas Elliman spinoff Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Codex DNA (DNAY) up another 7% after disclosing yesterday that it entered into a research collaboration and license agreement with Pfizer (PFE), pursuant to which the company and Pfizer agreed to collaborate to develop improvements to the company's existing proprietary BioXP platform
- FSD Pharma (HUGE) up 7% after announcing that its board has authorized the repurchase by the company of up to 2M of its Subordinate Class B Voting Shares from time to time over the next 12 months
- MicroStrategy (MSTR) up 1% after disclosing that, during the period between December 9 and December 29, the company purchased approximately 1,914 bitcoins for approximately $94.2M in cash
UP AFTER EARNINGS -
- BeyondSpring (BYSI) up 3%
DOWN AFTER EARNINGS -
LOWER -
- Vector Group (VGR) down 25% after completing the spin-off of Douglas Elliman (DOUG) into a standalone, publicly traded company
- Biogen (BIIB) down 6% after Samsung BioLogics said in a Korean regulatory filing that a report yesterday in South Korean newspaper Korea Economic Daily claiming that Samsung Group is in talks to acquire U.S. drugmaker Biogen is not true
- Micron (MU) down 1% after releasing a statement saying the closure of Xi'an has reduced Micron's team member and contractor workforce at its Xi'an site, resulting in some impact to output levels of DRAM assembly and test operations there
Symbols:
DNAY HUGE MSTR - $557.42 /
-10.94 (-1.92%)
BYSI DIDI VGR BIIB - $258.29 /
+22.27 (+9.44%)
MU DOUG Keywords: Fly Intel, Wall Street, Top Stories, Stocks